🇺🇸 FDA
Pipeline program

Bilateral Nucleus Accumbens DBS (Suzhou Sceneray)

RCT-YY2015-CRODS

Phase 3 other terminated

Quick answer

Bilateral Nucleus Accumbens DBS (Suzhou Sceneray) for Obsessive Compulsive Disorder is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Obsessive Compulsive Disorder
Phase
Phase 3
Modality
other
Status
terminated

Clinical trials